Full name
SCIENCEPHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical products
46.46.Z - Wholesale trade of pharmaceutical and medical products
68.11.Z - Buying and selling real estate on own account
68.20.Z - Rental and management of own or leased real estate
70.20.Z - Business and management consultancy activities
72.10.Z - Scientific research and development in natural and technical sciences
77.11.Z - Rental and leasing of passenger cars and light motor vehicles
96.99.Z - Other individual services not classified elsewhere
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 13,1 | 14,9 | 15,3 | 2,7 |
EBITDA | 5,2 | 8,9 | 1,5 | -83,7 |
Short time liabilities | 174,3 | 225,9 | 197,1 | -12,8 |
Equity capital | 17,3 | 22,7 | 37,9 | 67,1 |
Operating profit (EBIT) | 5,2 | 8,9 | 1,4 | -84,4 |
Assets | 192 | 248,7 | 235 | -5,5 |
Net profit (loss) | 13,1 | 14,9 | 15,2 | 2,6 |
Cash | 11,6 | 20,3 | 24,1 | 19,1 |
Net income from sale | 299 | 255,9 | 285,3 | 11,5 |
Liabilities and provisions for liabilities | 174,7 | 226 | 197,1 | -12,8 |
Working assets | 191,9 | 248,6 | 233,4 | -6,1 |
Depreciation | 0 | 0 | 0,1 | 93,2 |
% | % | % | p.p. | |
Profitability of capital | 75,8 | 65,4 | 40,2 | -25,2 |
Equity capital to total assets | 9 | 9,1 | 16,1 | 7 |
Gross profit margin | 4,4 | 5,8 | 5,3 | -0,5 |
EBITDA Margin | 1,7 | 3,5 | 0,5 | -3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 213 | 322 | 252 | -70 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane